Related Experiment Videos
A new radiopharmaceutical for gallbladder studies: 99mTc-Sn-LIDA complex
Nuklearmedizin. Nuclear Medicine
|April 1, 1977
Summary
A straightforward method for preparing technetium-99m tin-lidofenin (99mTc-Sn-LIDA) complex is presented. Animal studies and successful patient trials demonstrate its efficacy in evaluating gallbladder function.
Area of Science:
- Nuclear Medicine
- Radiopharmacy
- Diagnostic Imaging
Background:
- The development of effective radiopharmaceuticals is crucial for diagnostic imaging.
- Technetium-99m (99mTc) based agents are widely used due to their favorable physical properties.
Purpose of the Study:
- To describe a simple preparation method for the 99mTc-Sn-LIDA complex.
- To evaluate the biodistribution and blood clearance of this complex in animal models.
- To assess the clinical utility of 99mTc-Sn-LIDA for gallbladder function assessment.
Main Methods:
- Preparation of the 99mTc-Sn-LIDA complex using a simple method.
- Organ distribution studies in animal models.
- Blood clearance studies in animal models.
- Clinical application in patients for gallbladder function assessment.
Main Results:
- A simple and effective method for preparing 99mTc-Sn-LIDA was established.
- Animal studies provided data on organ distribution and blood clearance.
- Successful use in over 50 patients for gallbladder function assessment.
Conclusions:
- The described method yields a viable 99mTc-Sn-LIDA complex.
- The complex exhibits suitable characteristics for diagnostic applications.
- 99mTc-Sn-LIDA is a clinically useful agent for assessing gallbladder function.